Technology Networks

Thermo Fisher Scientific Announces Collaboration to Establish new Tokyo Biomarker Research Center
The collaboration aims to introduce MS-based technologies into Japan to advance personalized medicine and healthcare.

Biomarkers Found for Postmenopausal Cardiovascular Disease
Analysis of blood protein data from the Women’s Health Initiative cohorts has revealed new biomarkers for stroke and coronary heart disease.

Researchers Block Pathway that Performs Key Function in End-Stage Prostate Cancer Tumor Progression
UT Southwestern researchers find that blocking one of the enzymatic steps that allow the tumor to produce androgens could be the key in halting a tumor's growth.

Algeta Concludes Agreements for the Manufacture and Supply of Alpharadin for Future Commercial Sale
The signing of these agreements triggers a EUR 5 million milestone payment from Bayer Schering Pharma.

Protein Important in Diabetes may also Play a Key Role in Heart Disease, Other Disorders
In finding unsuspected links to other disease-related genes, the scientists may have identified future targets for drug treatments.

New Biotech Company Grows from MCG Diabetes and Genomic Research
Jinfiniti Biosciences, grown out of laboratory and clinical studies at MCG, is aimed at improving the diagnosis and treatment of diabetes and cancer.

Thermo Fisher Scientific and Intrinsic Bioprobes Collaborate to Develop MS Immunoassay Workflow
Turnkey MSIA solution allows researchers to differentiate and quantitate low-abundance intact proteins and their variants.

The EMBO Meeting 2010 - Advancing the life sciences
04 September 2010 - 07 September 2010

Barcelona, Spain
Submit late abstracts by 30 July & register until 15 August

Programme includes: presentations by 120 world-class researchers, e.g. Elizabeth Blackburn and Cliff Tabin, 21 workshops spanning the life sciences, stand-alone poster sessions, on-site childcare and plenty of opportunities to meet fellow scientists.

Drug Analysis 2010 - Antwerp, Belgium
21 September 2010 - 24 September 2010

This international symposium is organized by the Belgian Society of Pharmaceutical Sciences (BSPS) since 1983 and will cover all aspects of pharmaceutical and biomedical analysis, including emerging domains, such as ‘omics’, process analytical technology and green analysis.

Mass Spec Europe, Florence, Italy
09 November 2010 - 10 November 2010

Mass Spec Europe 2010, will build on the success of last years meeting, by delivering more top class speakers, giving their views and expert opinions on the latest, cutting-edge techniques being used within the mass spectrometry sector. Delegates will also benefit three other conferences which it is being co-located with, ensuring a cost effective trip.

Advances in Metabolic Profiling, Florence, Italy
09 November 2010 - 10 November 2010

Welcome to the 6th annual Advances in Metabolic Profiling conference and exhibition.
This year's event will be held in the beautiful and historic city of Florence.
The conference will be co-located with Mass Spec Europe, European Biomarkers Summit and Advances in Protein Crystallography. Registered delegates will have access to all four meetings ensuring a very cost-effective trip.


Post-doctoral position at INRA (France)
INRA
An 18-month post-doctoral position is available at INRA Clermont-Ferrand-Theix (France).The position is opened to both French and foreign applicants.

Engineer Technician, Fayetteville, Arizona, USA
SFC-Fluidics
SFC Fluidics is looking to hire a highly motivated, detail-oriented engineer technician.

oral communication skills . Experience with GMP and GLP desired

Computational Medicinal Chemistry Post-Doc Position, Siena, Italy
University of Siena
NatSynDrugs Is Seeking Candidates For a Computational Medicinal Chemistry Post-Doc Position

Program Development Manager, LasX Industries, MN, USA
LasX Industries
The position of Program Development Manager assumes the lead role for developing production processes for targeted programs, primarily in the micro-fluidics market.

Automation Engineer, Metabolism, Agios Pharmaceuticals, Cambridge, MA, USA
Agios Pharmaceuticals
With new research showing that cancer cells become addicted to using more nutrients than normal cells to promote their rapid growth, there is an unprecedented opportunity to create a new class of oncology therapeutics that target a fundamental and ubiquitous mechanism in cancer cells. The intersection of these two fields of research - cancer and metabolism- represents an important and novel approach to treating cancer.


Senior Scientist, Metabolism
Agios
Agios Pharmaceuticals is seeking a PhD Scientist to join a team that is building and applying a state-of-art approach to investigate the intersection of cancer cell biology and metabolism.




Metabolomics Platform Coordinator, CIBERDEM, Barcelona
CIBERDEM
The Metabolomics Platform is a research facility financed by CIBERDEM, the Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders. CIBERDEM is an initiative of the Carlos III Health Institute (Ministry of Science and Innovation, http://www.isciii.es), while the platform is located at the Universitat Rovira i Virgili (Tarragona, Spain).

Senior Fellow, Long Term Research in Metabolomics and Nutrient
PepsiCo
Establish and lead the LTR Pepsico Biology Innovation Lab (PIBL) Metabolomics and Nutrient Physiology research program and team.

US Field Application Scientist, Cell based assay technology
Langton Howarth
Our client supplies novel laboratory scale instrumentation, screening services and develops custom automation for life sciences companies spanning the healthcare, biotech and pharmaceutical sectors.
Due to expansion they now seek a US Field Application Scientist to support sales and customers of their high content screening/cell based assay technology.

Compound Management Technologist, St Jude Children's Research Hospital, Memphis, TN

St. Jude Children's Research Hospital, located in Memphis, Tennessee, is a premier center for research and treatment of potentially fatal childhood diseases, including cancer and certain blood, genetic, and immunodeficiency disorders. The hospital's mission is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. St. Jude is dedicated to providing unsurpassed patient care and to advancing the health of children through biomedical research.

Postdoctoral Research Associate
Northeastern University
The Center for Drug Discovery at Northeastern University is dedicated to designing and discovering novel medications, developing technologies, and training scientists in the multidisciplinary field of drug discovery. We are recruiting a Postdoctoral Research Associate with expertise in protein-based mass spectrometry and /or proteomics.

Assistant/Associate Professors
Chinese University of Hong Kong
The newly established School of Biomedical Sciences, Stem Cell and Regeneration theme is actively looking for stem cell biologist over the next 2 years.

Predicting hepatotoxicity: Reactive metabolite trapping using glutathione and freshly isolated hepatocytes
Department of In Vitro Sciences, Quotient Bioresearch (Rushden) Ltd

This poster presents our results to date using clozapine (a compound known to be associated with GSH-adduct formation) as substrate and using stable isotope GSH (GSH13C2,15N) to enhance specificity. In addition, all analyses have been conducted using an Waters Acquity UPLC-MS/MS. Results we have obtained in hepatocytes are compared against findings using human liver microsomes (HLM).

The Human Serum Metabolome
Western Human Nutrition Research Center

As part of our objective to systematically characterize the human metabolome and advance the fields of quantitative metabolomics, we present a global metabolic profiling of the human serum. Our experimental results indicated that global metabolic profiling methods can routinely detect more than 4200 different compounds in serum.

Nucleic Acid Reagents and Experimental Results in the NCBI Probe Database
National Center for Biotechnology Information, NIH, Bethesda, MD

Five years ago, the NCBI Probe database (ProbeDB) was established to provide a centralized archive of molecular probes used in biomedical applications. Currently ProbeDB contains around 10 million probes of 65 types including gene silencing agents, in situ hybridization probes, and probes for variation analysis and genome mapping. Presently, ProbeDB is the largest and most extensive database of this type available in public domain.
  

Conquering Biological Variability by Crossover Designs and Multilevel Data Analysis in Nutritional Metabolomics Studies

Johan Westerhuis, Assistant Professor, Swammerdam Institute for Life Sciences, speaking at Advances in Metabolic Profiling 2009


The Robust Metabolic Network Adaptations in Ultifactorial Diseases as New Targets for Novel Designed Therapies

Marta Cascante, Professor, University of Barcelona, speaking at Advances in Metabolic Profiling 2009

RADAR, a Xevo TQ-S function, combined with Low-High pH UPLC Screening for Fast, Simple Bioanalysis Methods Development
Waters Corporation

Here, we demonstrate the productivity gains possible with Xevo TQ-S for use in bioanalytical methods. Xevo TQ-S employs a unique RADAR functionality to collect data in the time scale of a narrow 1- to 2-second peak.

The Transcreener® ADP2 FI Assay performed on PHERAstar and Omega microplate readers
BMG LABTECH


Multiplexed Diagnostics 2010
Select Biosciences Ltd

The multiplexed diagnostics market has grown rapidly and generated sales of approximately $2.4 billon in 2009, but is now balanced on multiple tipping points.